Metanoi Therapeutics
"I believe we can discover a non-toxic treatment for cancer."
--Guilherme Cantuaria, M.D., Ph.D.
Metanoi Therapeutics
"I believe we can discover a non-toxic treatment for cancer."
--Guilherme Cantuaria, M.D., Ph.D.
A research-stage biotechnology company for cancer therapies
What is Metanoi
What is Metanoi
What is Metanoi
Metanoia is a Greek word meaning a transformation in one's outlook or in the way one views life. Metanoi Therapeutics, Inc. was founded with the aim of changing the way we look at cancer by capitalizing on untapped biomedical breakthroughs.
How We Work
What is Metanoi
What is Metanoi
By engaging in productive collaborations with world-class scientific visionaries, Metanoi has been able to create innovative medicines to address the unmet needs of patients afflicted with life-threatening diseases. Metanoi's lead innovations include methods for treating cancer, including administering a composition of lipid biosynthetic compounds.
Leadership
What is Metanoi
Leadership
Metanoi is led by President and CEO, Guilherme Cantuaria, M.D., Ph.D., who is among the most distinguished and experienced robotic gynecologic cancer surgeons in the country. Dr. Cantuaria’s lectures nationally and internationally. In addition, he has authored and co-authored numerous publications focusing on cancers.
Investors
Why Invest?
Metanoi is well-positioned to advance its promising therapies to proof of relevance clinical studies.
How?
For more detailed information regarding investment or partnering opportunities, please contact us.
Contact Us
Please send us a message or call us for an appointment.